JFL Life Sciences Limited (NSEI: JFLLIFE)
Health Care · Pharmaceuticals · IN
Rs10.00
-3.38% today · -21.3% 1Y
JFL Life Sciences Limited (NSEI: JFLLIFE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.43M.
Over the last twelve months the share price has lost 21.3%, trading between 8.55 and 15.40.
Tweenvest scores JFL Life Sciences Limited across four factors: quality 61/100, value 74/100, growth 98/100. Its strongest factor is growth.
JFLLIFE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.43M
- Revenue (TTM)
- $13.84M
- P/E
- 4.89
- EPS
- 2.05
- Dividend yield
- —
- Beta (5Y)
- -0.27
- 52-week high
- Rs15.40
- 52-week low
- Rs8.55
- Avg volume (3M)
- —
- Shares outstanding
- 33.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Murae Organisor LimitedBSE: 542724 | $3.76M | Rs— | — |
| Sanai Health Industry Group Company LimitedSEHK: 1889 | $3.72M | HK$0.19 | +3.80% |
| 1933 Industries Inc.CNSX: TGIF | $3.65M | CA$0.01 | +100.00% |
| PharmaTher Holdings Ltd.CNSX: PHRM | $3.51M | CA$0.06 | +10.00% |
| Jupiter Neurosciences, Inc.NasdaqCM: JUNS | $3.36M | $2.77 | +8.63% |
| IM Cannabis Corp.NasdaqCM: IMCC | $3.36M | $1.72 | -15.69% |
| ODI Pharma AB (publ)NGM: ODI | $3.32M | Skr1.81 | -7.18% |
| Cadrenal Therapeutics, Inc.NasdaqCM: CVKD | $3.32M | $0.93 | -4.39% |
Figures last refreshed Oct 4, 2026.